View source for Molecular Computing Patent Application Trends 2025

== Molecular Computing Patent Application Filing Activity ==
== Molecular Computing patent applications in 2025 ==
[[File:Molecular_Computing_Monthly_Patent_Applications_2025_-_Up_to_February 2025.png|border|800px]]

== Top Technology Areas in Molecular Computing ==
[[File:Top_Technology_Areas_in_Molecular_Computing_2025_-_Up_to_February 2025.png|border|800px]]

=== Top CPC Codes ===
* [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available)
** Count: 5 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available)
** Count: 5 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_C07K14/7051|C07K14/7051]] (No explanation available)
** Count: 3 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61P35/00|A61P35/00]] (No explanation available)
** Count: 3 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K2239/31|A61K2239/31]] (No explanation available)
** Count: 2 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K2239/38|A61K2239/38]] (No explanation available)
** Count: 2 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K39/464412|A61K39/464412]] (No explanation available)
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_C07K2317/92|C07K2317/92]] (No explanation available)
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_C07K2319/02|C07K2319/02]] (No explanation available)
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_C07K2319/03|C07K2319/03]] (No explanation available)
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]

== Top Companies in Molecular Computing 2025 ==
[[File:Top_Companies_in_Molecular_Computing.png|border|800px]]

=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
* Number of Molecular Computing patents: 2
* Top CPC codes:
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 2 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 2 patents
** [[:Category:CPC_C07K14/7051|C07K14/7051]] (No explanation available): 1 patents
* Recent patents:
** [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] (20250130)
** [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] (20250130)
=== [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_A61K39/464402|A61K39/464402]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 1 patents
* Recent patents:
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
=== [[:Category:Molecular Partners AG|Molecular Partners AG]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_C07K14/47|C07K14/47]] (No explanation available): 1 patents
** [[:Category:CPC_A61K45/06|A61K45/06]] (No explanation available): 1 patents
** [[:Category:CPC_A61K38/00|A61K38/00]] (No explanation available): 1 patents
* Recent patents:
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
=== [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_C07K14/4702|C07K14/4702]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 1 patents
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_C12N15/52|C12N15/52]] (No explanation available): 1 patents
** [[:Category:CPC_C12N1/20|C12N1/20]] (No explanation available): 1 patents
** [[:Category:CPC_C12N9/0006|C12N9/0006]] (No explanation available): 1 patents
* Recent patents:
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
=== [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_A61K35/17|A61K35/17]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 1 patents
* Recent patents:
** [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] (20250109)

== New Companies in Molecular Computing (Last Month) ==
[[File:New_Companies_in_Molecular_Computing_Last_Month.png|border|800px]]

No new companies detected in the last month.

== Emerging Technology Areas in Molecular Computing ==
[[File:Emerging_Technology_Areas_in_Molecular_Computing.png|border|800px]]

* [[:Category:CPC_C12N2740/15041|C12N2740/15041]] (No explanation available)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K2239/22|A61K2239/22]] (No explanation available)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K2239/21|A61K2239/21]] (No explanation available)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K2239/17|A61K2239/17]] (No explanation available)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K2239/13|A61K2239/13]] (No explanation available)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_C07K16/28|C07K16/28]] (No explanation available)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K35/17|A61K35/17]] (No explanation available)
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_C12Y401/01005|C12Y401/01005]] (No explanation available)
** Count: 1 patents
** Example: [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]]
* [[:Category:CPC_C12Y401/01004|C12Y401/01004]] (No explanation available)
** Count: 1 patents
** Example: [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]]

== Top Companies in Emerging Molecular Computing Technologies 2025==
[[File:Top_Companies_in_Emerging_Molecular_Computing_Technologies.png|border|800px]]

* [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 8 patents
* [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 2 patents

== Top Inventors in Molecular Computing ==
[[File:Top_50_Inventors_in_Molecular_Computing.png|border|800px]]

=== [[:Category:Wei XU|Wei XU]] ===
* Number of Molecular Computing patents: 2
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]]: 1 patents
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
** [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] (20250109)
=== [[:Category:Huafeng WEI|Huafeng WEI]] ===
* Number of Molecular Computing patents: 2
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]]: 1 patents
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
** [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] (20250109)
=== [[:Category:Wendell A. Lim|Wendell A. Lim of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] (20250130)
=== [[:Category:Hideho Okada|Hideho Okada of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] (20250130)
=== [[:Category:Kole T. Roybal|Kole T. Roybal of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] (20250130)
=== [[:Category:Joseph H. Choe|Joseph H. Choe of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] (20250130)
=== [[:Category:Payal B. Watchmaker|Payal B. Watchmaker of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] (20250130)
=== [[:Category:James A. WELLS|James A. WELLS of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] (20250130)
=== [[:Category:Zachary B. HILL|Zachary B. HILL of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] (20250130)
=== [[:Category:Alexander J. MARTINKO|Alexander J. MARTINKO of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] (20250130)
=== [[:Category:Diana Binia DAROWSKI|Diana Binia DAROWSKI]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
=== [[:Category:Dan XU|Dan XU]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
=== [[:Category:Ying YAO|Ying YAO]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
=== [[:Category:Bianka PRINZ|Bianka PRINZ]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
=== [[:Category:Nadthakarn BOLAND|Nadthakarn BOLAND]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
=== [[:Category:James GEOGHEGAN|James GEOGHEGAN]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
=== [[:Category:Simon Fontaine|Simon Fontaine]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:Molecular Partners AG|Molecular Partners AG]]: 1 patents
* Recent patents:
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
=== [[:Category:Andreas Bosshart|Andreas Bosshart]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:Molecular Partners AG|Molecular Partners AG]]: 1 patents
* Recent patents:
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
=== [[:Category:Bernd Schlereth|Bernd Schlereth]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:Molecular Partners AG|Molecular Partners AG]]: 1 patents
* Recent patents:
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
=== [[:Category:Daniel Steiner|Daniel Steiner]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:Molecular Partners AG|Molecular Partners AG]]: 1 patents
* Recent patents:
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
=== [[:Category:Marcel Walser|Marcel Walser]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:Molecular Partners AG|Molecular Partners AG]]: 1 patents
* Recent patents:
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
=== [[:Category:Max Jan|Max Jan of Boston MA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:Quinlan L. Sievers|Quinlan L. Sievers of Boston MA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:Benjamin Ebert|Benjamin Ebert of Boston MA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:Marcela Maus|Marcela Maus of Boston MA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:Mark Anton HELD|Mark Anton HELD of Germantown MD (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 1 patents
* Recent patents:
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
=== [[:Category:Xinhua ZHAO|Xinhua ZHAO of Germantown MD (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 1 patents
* Recent patents:
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
=== [[:Category:Lily Yuin CHAO|Lily Yuin CHAO of Germantown MD (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 1 patents
* Recent patents:
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
=== [[:Category:Na TRINH|Na TRINH of Germantown MD (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 1 patents
* Recent patents:
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
=== [[:Category:James KEALEY|James KEALEY of Germantown MD (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 1 patents
* Recent patents:
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
=== [[:Category:Kevin Lee DIETZEL|Kevin Lee DIETZEL of Germantown MD (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 1 patents
* Recent patents:
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
=== [[:Category:Shengjie GUO|Shengjie GUO]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] (20250109)
=== [[:Category:Jianan CHEN|Jianan CHEN]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] (20250109)
=== [[:Category:Guozhi CHEN|Guozhi CHEN]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 1 patents
* Recent patents:
** [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] (20250109)

== Top Collaborations in Molecular Computing ==
[[File:Top_20_Collaborations_in_Molecular_Computing.png|border|800px]]

== Top US States for Molecular Computing Inventors ==
[[File:Top_10_US_States_for_Molecular_Computing_Inventors.png|border|800px]]


== Top Cities for Molecular Computing Inventors ==
[[File:Top_20_Cities_for_Molecular_Computing_Inventors.png|border|800px]]

* Suzhou, Jiangsu: 13 inventors
* San Francisco: 8 inventors
* Germantown: 6 inventors
* Zürich-Schlieren: 5 inventors
* Boston: 4 inventors

[[Category:Molecular Computing]]
[[Category:Patent Application Trends by Technology in 2025]]